Get started
Author

Munjid Al Harthy

Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary renal cell cancer.
2020 · Ramaprasad Srinivasan, Sandeep Gurram, et al. · Journal of Clinical Oncology · 98
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
2025 · Ramaprasad Srinivasan, Sandeep Gurram, et al. · New England Journal of Medicine · 42
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer
2021 · Ravi A Madan, Fatima Karzai, et al. · Journal for ImmunoTherapy of Cancer · 34
PDF
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer
2020 · Ravi A. Madan, Fatima H. Karzai, et al. · British Journal of Urology · 18
Novel immunotherapy combinations for genitourinary cancers
2020 · Munjid Al Harthy, Jason Redman, et al. · Expert Opinion on Biological Therapy · 12
Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis
2023 · Aafaque Ahmad Khan, Nahad Al-Mahrouqi, et al. · Cancers · 9
PDF
The changing landscape of systemic therapy in metastatic renal cell carcinoma: an update.
2020 · Sandeep Gurram, Munjid Al Harthy, et al. · Discovery Medicine · 8
Predictors and outcomes of multi-drug–resistant gram-negative bacteremia in patients with cancer: A retrospective cohort study at a tertiary cancer center in Oman
2024 · Bassem Awada, Jorge Abarca, et al. · IJID Regions · 6
Anthracycline‐induced acute myocarditis and ventricular fibrillation arrest
2017 · Vincent A. Pallazola, Joseph C. Murray, et al. · American Journal of Hematology · 5
PDF
A phase II study of the selective MET kinase inhibitor INC280 in advanced papillary renal cell cancer.
2020 · Paul Denis Leger, Daniel da Motta Girardi, et al. · Journal of Clinical Oncology · 4
Efficacy of abiraterone and enzalutamide in patients who had disease progression within twelve months of completing docetaxel for metastatic castration sensitive prostate cancer.
2019 · Gang Chen, David James VanderWeele, et al. · Journal of Clinical Oncology · 3
A phase I and randomized phase II study of cabozantinib plus docetaxel and prednisone (C+DP) versus docetaxel and prednisone (DP) alone in metastatic castrate-resistant prostate cancer (mCRPC).
2019 · Munjid Al Harthy, Ravi Amrit Madan, et al. · Journal of Clinical Oncology · 3
Intensifying the Hormonal and Radiation Treatment in Prostate Cancer Presenting With Bulky Pelvic Lymph Nodes: An Opportunity for a New Paradigm
2024 · Agha H Khan, Nadeem Pervez, et al. · Cureus · 1
PDF
PSMA PET findings in patients with undetectable PSA more than 3 years after docetaxel for metastatic castration-sensitive prostate cancer (mCSPC).
2022 · Mohammad O. Atiq, Shruti U. Gandhy, et al. · Journal of Clinical Oncology · 1
Intermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerability
2018 · M. Al Harthy, H. Singh, et al. · Annals of Oncology · 1
¹⁷⁷Lu-PSMA Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer With Complex Renal Conditions: A Case Series
2026 · Sharjeel Usmani, Anas al Balushi, et al. · Clinical Nuclear Medicine
PSMA PET/CT-Guided Multimodal Therapy for Pelvic Lymph Node Positive and De Novo Low-Volume Metastatic Prostate Cancer: A Gulf Region Single-Institution Experience
2026 · Nadeem Pervez, Benazir Mir Khan, et al. · Diseases
PDF
From Diagnosis to Disclosure: Navigating Genetic Counseling Dilemmas in BRCA2 ‐Associated Prostate Cancer in the Middle East
2026 · Chantel van Wyk, Reem Abdulrahim, et al. · Case Reports in Genetics
Radiotherapy Treatment with Radical Doses in De Novo Low Burden Metastatic Prostate Cancer: Early Outcomes Report.
2024 · B. mir Khan, N. Pervez, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Pd40-11 Clinical Activity of Nivolumab in Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (hlrcc)-associated Kidney Cancer
2021 · Alexis Rompre-Brodeur, Julia Friend, et al. · The Journal of Urology
Clinical efficacy of abiraterone and enzalutamide metastatic castration sensitive prostate cancer patients who progressed rapidly on docetaxel with a genomic analysis.
2019 · Gang Chen, David James VanderWeele, et al. · Journal of Clinical Oncology
Antifibrinolytics: Indications and Precautions
2016 · Munjid Al Harthy, Peter Kouides · Springer eBooks
Works count: 22
Citation count: 245
H-index: 7
I10-index: 5
Year
Topic
Type